secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kiromic Biopharma, Inc. (—)
CIK:        0001792581
Form:       8-K
Filed at:   2023-07-19T23:59:59+00:00
Accession:  0001558370-23-011964
Event type: debt
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kiromic BioPharma exchanges $6M of 25% Senior Notes for Series C Preferred Stock
--------------------------------------------------------------------------------

- Exchanged $6M aggregate principal of 25% Senior Secured Convertible Promissory Notes for 6,000 shares of Series C Convertible Voting Preferred Stock.
- Filed Certificate of Amendment designating 14,000 authorized shares of Series C Preferred Stock with Delaware Secretary of State.
- Exchange executed under Section 3(a)(9) exemption; Series C stock issued in reliance on Section 4(a)(2) of Securities Act.
- Holder released all claims related to the Exchange Notes; holding period of Preferred Stock tacks back to original note issuance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1792581/000155837023011964/0001558370-23-011964-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1792581/000155837023011964/krbp-20230718x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-011964

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer